{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T04:57:24Z","timestamp":1792299444091,"version":"4.4.0"},"reference-count":96,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2021,3,31]],"date-time":"2021-03-31T00:00:00Z","timestamp":1617148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,3,31]],"date-time":"2021-03-31T00:00:00Z","timestamp":1617148800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1007\/s10067-021-05711-w","type":"journal-article","created":{"date-parts":[[2021,3,31]],"date-time":"2021-03-31T18:03:10Z","timestamp":1617213790000},"page":"3883-3896","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":82,"title":["Expanding spectrum of DADA2: a review of phenotypes, genetics, pathogenesis and treatment"],"prefix":"10.1007","volume":"40","author":[{"given":"Benzeeta","family":"Pinto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prateek","family":"Deo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susmita","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arshi","family":"Syal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0813-1243","authenticated-orcid":false,"given":"Aman","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,31]]},"reference":[{"key":"5711_CR1","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1056\/NEJMoa1307361","volume":"370","author":"Q Zhou","year":"2014","unstructured":"Zhou Q, Yang D, Ombrello AK, Zavialov AV, Toro C, Zavialov AV, Stone DL, Chae JJ, Rosenzweig SD, Bishop K, Barron KS, Kuehn HS, Hoffmann P, Negro A, Tsai WL, Cowen EW, Pei W, Milner JD, Silvin C, Heller T, Chin DT, Patronas NJ, Barber JS, Lee CCR, Wood GM, Ling A, Kelly SJ, Kleiner DE, Mullikin JC, Ganson NJ, Kong HH, Hambleton S, Candotti F, Quezado MM, Calvo KR, Alao H, Barham BK, Jones A, Meschia JF, Worrall BB, Kasner SE, Rich SS, Goldbach-Mansky R, Abinun M, Chalom E, Gotte AC, Punaro M, Pascual V, Verbsky JW, Torgerson TR, Singer NG, Gershon TR, Ozen S, Karadag O, Fleisher TA, Remmers EF, Burgess SM, Moir SL, Gadina M, Sood R, Hershfield MS, Boehm M, Kastner DL, Aksentijevich I (2014) Early-onset stroke and vasculopathy associated with mutations in ADA2. N Engl J Med 370:911\u2013920. https:\/\/doi.org\/10.1056\/NEJMoa1307361","journal-title":"N Engl J Med"},{"key":"5711_CR2","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1056\/NEJMoa1307362","volume":"370","author":"PN Elkan","year":"2014","unstructured":"Elkan PN, Pierce SB, Segel R, Walsh T, Barash J, Padeh S, Zlotogorski A, Berkun Y, Press JJ, Mukamel M, Voth I, Hashkes PJ, Harel L, Hoffer V, Ling E, Yalcinkaya F, Kasapcopur O, Lee MK, Klevit RE, Renbaum P, Weinberg-Shukron A, Sener EF, Schormair B, Zeligson S, Marek-Yagel D, Strom TM, Shohat M, Singer A, Rubinow A, Pras E, Winkelmann J, Tekin M, Anikster Y, King MC, Levy-Lahad E (2014) Mutant adenosine deaminase 2 in a polyarteritis nodosa vasculopathy. N Engl J Med 370:921\u2013931. https:\/\/doi.org\/10.1056\/NEJMoa1307362","journal-title":"N Engl J Med"},{"key":"5711_CR3","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/s10875-018-0525-8","volume":"38","author":"I Meyts","year":"2018","unstructured":"Meyts I, Aksentijevich I (2018) Deficiency of adenosine deaminase 2 (DADA2): Updates on the phenotype, genetics, pathogenesis, and treatment. J Clin Immunol 38:569\u2013578. https:\/\/doi.org\/10.1007\/s10875-018-0525-8","journal-title":"J Clin Immunol"},{"key":"5711_CR4","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1002\/art.41500","volume":"73","author":"A Sharma","year":"2020","unstructured":"Sharma A, Naidu G, Sharma V, Jha S, Dhooria A, Dhir V, Bhatia P, Sharma V, Bhattad S, Chengappa, Gupta V, Misra DP, Chavan PP, Malaviya S, Dudam R, Sharma B, Kumar S, Bhojwani R, Gupta P, Agarwal V, Sharma K, Singhal M, Rathi M, Nada R, Minz RW, Chaturvedi V, Aggarwal A, Handa R, Grossi A, Gattorno M, Huang Z, Wang J, Jois R, Negi V, Khubchandani R, Jain S, Arostegui JI, Chambers EP, Hershfield MS, Aksentijevich I, Zhou Q, Lee PY (2020) Deficiency of adenosine deaminase 2 (DADA2) in adults and children: experience from India. Arthritis Rheumatol 73:276\u2013285. https:\/\/doi.org\/10.1002\/art.41500","journal-title":"Arthritis Rheumatol"},{"key":"5711_CR5","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1093\/rheumatology\/kev439","volume":"55","author":"JM Van Montfrans","year":"2016","unstructured":"Van Montfrans JM, Hartman EAR, Braun KPJ, Hennekam EAM, Hak EA, Nederkoorn PJ, Westendorp WF, Bredius RGM, Kollen WJW, Sch\u00f6lvinck EH, Elizabeth Legger G, Meyts I, Liston A, Lichtenbelt KD, Giltay JC, Van Haaften G, De Vries Simons GM, Leavis H, Sanders CJG, Bierings MB, Nierkens S, Van Gijn ME (2016) Phenotypic variability in patients with ADA2 deficiency due to identical homozygous R169Q mutations. Rheumatology (Oxford) 55:902\u2013910. https:\/\/doi.org\/10.1093\/rheumatology\/kev439","journal-title":"Rheumatology (Oxford)"},{"key":"5711_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fped.2018.00282","volume":"6","author":"PY Lee","year":"2018","unstructured":"Lee PY (2018) Vasculopathy, immunodeficiency, and bone marrow failure: the intriguing syndrome caused by deficiency of adenosine deaminase 2. Front Pediatr 6:1\u20138. https:\/\/doi.org\/10.3389\/fped.2018.00282","journal-title":"Front Pediatr"},{"key":"5711_CR7","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1016\/j.jaci.2019.12.908","volume":"145","author":"PY Lee","year":"2020","unstructured":"Lee PY, Kellner ES, Huang Y, Furutani E, Huang Z, Bainter W, Alosaimi MF, Stafstrom K, Platt CD, Stauber T, Raz S, Tirosh I, Weiss A, Jordan MB, Krupski C, Eleftheriou D, Brogan P, Sobh A, Baz Z, Lefranc G, Irani C, Kilic SS, El-Owaidy R, Lokeshwar MR, Pimpale P, Khubchandani R, Chambers EP, Chou J, Geha RS, Nigrovic PA, Zhou Q (2020) Genotype and functional correlates of disease phenotype in deficiency of adenosine deaminase 2 (DADA2). J Allergy Clin Immunol 145:1664\u20131672.e10. https:\/\/doi.org\/10.1016\/j.jaci.2019.12.908","journal-title":"J Allergy Clin Immunol"},{"key":"5711_CR8","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1111\/1756-185X.13283","volume":"22","author":"A Human","year":"2019","unstructured":"Human A, Pagnoux C (2019) Diagnosis and management of ADA2 deficient polyarteritis nodosa. Int J Rheum Dis 22:69\u201377. https:\/\/doi.org\/10.1111\/1756-185X.13283","journal-title":"Int J Rheum Dis"},{"key":"5711_CR9","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1189\/jlb.1109764","volume":"88","author":"AV Zavialov","year":"2010","unstructured":"Zavialov AV, Gracia E, Glaichenhaus N, Franco R, Zavialov AV, Lauvau G (2010) Human adenosine deaminase 2 induces differentiation of monocytes into macrophages and stimulates proliferation of T helper cells and macrophages. J Leukoc Biol 88:279\u2013290. https:\/\/doi.org\/10.1189\/jlb.1109764","journal-title":"J Leukoc Biol"},{"key":"5711_CR10","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1007\/s00018-016-2357-0","volume":"74","author":"Y Kaljas","year":"2017","unstructured":"Kaljas Y, Liu C, Skaldin M, Wu C, Zhou Q, Lu Y, Aksentijevich I, Zavialov AV (2017) Human adenosine deaminases ADA1 and ADA2 bind to different subsets of immune cells. Cell Mol Life Sci 74:555\u2013570. https:\/\/doi.org\/10.1007\/s00018-016-2357-0","journal-title":"Cell Mol Life Sci"},{"key":"5711_CR11","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s00109-013-0997-1","volume":"91","author":"H Karmouty-Quintana","year":"2013","unstructured":"Karmouty-Quintana H, Xia Y, Blackburn MR (2013) Adenosine signaling during acute and chronic disease states. J Mol Med (Berl) 91:173\u2013181. https:\/\/doi.org\/10.1007\/s00109-013-0997-1","journal-title":"J Mol Med (Berl)"},{"key":"5711_CR12","doi-asserted-by":"publisher","unstructured":"Hask\u00f3 G, Cronstein B (2013) Regulation of inflammation by adenosine. Front Immunol 4. https:\/\/doi.org\/10.3389\/fimmu.2013.00085","DOI":"10.3389\/fimmu.2013.00085"},{"key":"5711_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1546-0096-12-44","volume":"12","author":"A Belot","year":"2014","unstructured":"Belot A, Wassmer E, Twilt M, Lega JC, Zeef LAH, Oojageer A, Kasher PR, Mathieu AL, Malcus C, Demaret J, Fabien N, Collardeau-Frachon S, Mechtouff L, Derex L, Walzer T, Rice GI, Durieu I, Crow YJ (2014) Mutations in CECR1 associated with a neutrophil signature in peripheral blood. Pediatr Rheumatol 12:1\u20137. https:\/\/doi.org\/10.1186\/1546-0096-12-44","journal-title":"Pediatr Rheumatol"},{"key":"5711_CR14","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1182\/blood.2018892752","volume":"134","author":"C Carmona-Rivera","year":"2019","unstructured":"Carmona-Rivera C, Khaznadar SS, Shwin KW, Irizarry-Caro JA, O\u2019Neil LJ, Liu Y, Jacobson KA, Ombrello AK, Stone DL, Tsai WL, Kastner DL, Aksentijevich I, Kaplan MJ, Grayson PC (2019) Deficiency of adenosine deaminase 2 triggers adenosine-mediated NETosis and TNF production in patients with DADA2. Blood 134:395\u2013406. https:\/\/doi.org\/10.1182\/blood.2018892752","journal-title":"Blood"},{"key":"5711_CR15","doi-asserted-by":"publisher","first-page":"523","DOI":"10.3899\/jrheum.180045","volume":"46","author":"A Insalaco","year":"2019","unstructured":"Insalaco A, Moneta GM, Pardeo M, Caiello I, Messia V, Bracaglia C, Passarelli C, De Benedetti F (2019) Variable clinical phenotypes and relation of interferon signature with disease activity in ADA2 deficiency. J Rheumatol 46:523\u2013526. https:\/\/doi.org\/10.3899\/jrheum.180045","journal-title":"J Rheumatol"},{"key":"5711_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/rmdopen-2015-000236","volume":"2","author":"F Uettwiller","year":"2016","unstructured":"Uettwiller F, Sarrabay G, Rodero MP, Rice GI, Lagrue E, Marot Y, Deiva K, Touitou I, Crow YJ, Quartier P (2016) ADA2 deficiency: case report of a new phenotype and novel mutation in two sisters. RMD Open 2:1\u20135. https:\/\/doi.org\/10.1136\/rmdopen-2015-000236","journal-title":"RMD Open"},{"key":"5711_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12969-017-0193-x","volume":"15","author":"A Skrabl-Baumgartner","year":"2017","unstructured":"Skrabl-Baumgartner A, Plecko B, Schmidt WM, K\u00f6nig N, Hershfield M, Gruber-Sedlmayr U, Lee-Kirsch MA (2017) Autoimmune phenotype with type i interferon signature in two brothers with ADA2 deficiency carrying a novel CECR1 mutation. Pediatr Rheumatol 15:1\u20135. https:\/\/doi.org\/10.1186\/s12969-017-0193-x","journal-title":"Pediatr Rheumatol"},{"key":"5711_CR18","doi-asserted-by":"publisher","first-page":"12367","DOI":"10.1074\/jbc.M109.083527","volume":"285","author":"AV Zavialov","year":"2010","unstructured":"Zavialov AV, Yu X, Spillmann D, Lauvau G, Zavialov AV (2010) Structural basis for the growth factor activity of human adenosine deaminase ADA2. J Biol Chem 285:12367\u201312377. https:\/\/doi.org\/10.1074\/jbc.M109.083527","journal-title":"J Biol Chem"},{"key":"5711_CR19","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1002\/art.40147","volume":"69","author":"J Schepp","year":"2017","unstructured":"Schepp J, Proietti M, Frede N, Buchta M, H\u00fcbscher K, Rojas Restrepo J, Goldacker S, Warnatz K, Pachlopnik Schmid J, Duppenthaler A, Lougaris V, Uriarte I, Kelly S, Hershfield M, Grimbacher B (2017) Screening of 181 patients with antibody deficiency for deficiency of adenosine deaminase 2 sheds new light on the disease in adulthood. Arthritis Rheumatol 69:1689\u20131700. https:\/\/doi.org\/10.1002\/art.40147","journal-title":"Arthritis Rheumatol"},{"key":"5711_CR20","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1016\/j.celrep.2013.05.022","volume":"3","author":"F Schena","year":"2013","unstructured":"Schena F, Volpi S, Faliti CE, Penco F, Santi S, Proietti M, Schenk U, Damonte G, Salis A, Bellotti M, Fais F, Tenca C, Gattorno M, Eibel H, Rizzi M, Warnatz K, Idzko M, Ayata CK, Rakhmanov M, Galli T, Martini A, Canossa M, Grassi F, Traggiai E (2013) Dependence of immunoglobulin class switch recombination in B cells on vesicular release of ATP and CD73 ectonucleotidase activity. Cell Rep 3:1824\u20131831. https:\/\/doi.org\/10.1016\/j.celrep.2013.05.022","journal-title":"Cell Rep"},{"key":"5711_CR21","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/eji.202048549","volume":"51","author":"F Schena","year":"2020","unstructured":"Schena F, Penco F, Volpi S, Pastorino C, Caorsi R, Kalli F, Fenoglio D, Salis A, Bertoni A, Prigione I, Bocca P, Insalaco A, De Benedetti F, Antonini F, Grossi A, Signa S, Damonte G, Ceccherini I, Filaci G, Traggiai E, Gattorno M (2020) Dysregulation in B cell responses and T follicular helper cell function in ADA2 deficiency patients. Eur J Immunol 51:4\u20135. https:\/\/doi.org\/10.1002\/eji.202048549","journal-title":"Eur J Immunol"},{"key":"5711_CR22","unstructured":"Infevers: an online database for autoinflammatory mutations. Copyright. Available at https:\/\/infevers.umai-montpellier.fr\/. Accessed: 17th February 2021"},{"key":"5711_CR23","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1093\/nar\/gkg031","volume":"31","author":"CS de Menthi\u00e8re","year":"2003","unstructured":"de Menthi\u00e8re CS, Terri\u00e8re S, Pugn\u00e8re D, Ruiz M, Demaille J, Touitou I (2003) INFEVERS: the registry for FMF and hereditary inflammatory disorders mutations. Nucleic Acids Res 31:282\u2013285","journal-title":"Nucleic Acids Res"},{"key":"5711_CR24","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1002\/art.40913","volume":"71","author":"KM Gibson","year":"2019","unstructured":"Gibson KM, Morishita KA, Dancey P, Moorehead P, Dr\u00f6gem\u00f6ller B, Han X, Graham J, Hancock REW, Foell D, Benseler S, Luqmani R, Yeung RSM, Shenoi S, Bohm M, Rosenberg AM, Ross CJ, Cabral DA, Brown KL (2019) Identification of novel adenosine deaminase 2 gene variants and varied clinical phenotype in pediatric vasculitis. Arthritis Rheumatol 71:1747\u20131755. https:\/\/doi.org\/10.1002\/art.40913","journal-title":"Arthritis Rheumatol"},{"key":"5711_CR25","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1007\/s00431-014-2320-8","volume":"173","author":"N Garg","year":"2014","unstructured":"Garg N, Kasapcopur O, Foster J, Barut K, Tekin A, K\u0131z\u0131lk\u0131l\u0131\u00e7 O, Tekin M (2014) Novel adenosine deaminase 2 mutations in a child with a fatal vasculopathy. Eur J Pediatr 173:827\u2013830. https:\/\/doi.org\/10.1007\/s00431-014-2320-8","journal-title":"Eur J Pediatr"},{"key":"5711_CR26","first-page":"S177","volume":"36","author":"P Lamprecht","year":"2018","unstructured":"Lamprecht P, Humrich JY, Diebold I, Riemekasten G (2018) Diagnosis of deficiency of adenosine deaminase 2 with early onset polyarteritis nodosa in an adult patient with a novel compound heterozygous CECR1 mutation. Clin Exp Rheumatol 36:S177","journal-title":"Clin Exp Rheumatol"},{"key":"5711_CR27","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1007\/s10875-019-00697-2","volume":"39","author":"HJ Chong-Neto","year":"2019","unstructured":"Chong-Neto HJ, Segundo GRS, Bandeira M, Chong-Silva DC, Ros\u00e1rio CS, Riedi CA, Hershfield MS, Ochs H, Torgerson T, Ros\u00e1rio NA (2019) Homozygous splice ADA2 gene mutation causing ADA-2 deficiency. J Clin Immunol 39:842\u2013845. https:\/\/doi.org\/10.1007\/s10875-019-00697-2","journal-title":"J Clin Immunol"},{"key":"5711_CR28","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1007\/s10875-020-00817-3","volume":"40","author":"O Schnappauf","year":"2020","unstructured":"Schnappauf O, Zhou Q, Moura NS, Ombrello AK, Michael DG, Deuitch N, Barron K, Stone DL, Hoffmann P, Hershfield M, Applegate C, Bjornsson HT, Beck DB, Witmer PD, Sobreira N, Wohler E, Chiorini JA, Center TAG, Dalgard CL, Center NIS, Kastner DL, Aksentijevich I (2020) Deficiency of adenosine deaminase 2 (DADA2): hidden variants, reduced penetrance, and unusual inheritance. J Clin Immunol 40:917\u2013926. https:\/\/doi.org\/10.1007\/s10875-020-00817-3","journal-title":"J Clin Immunol"},{"key":"5711_CR29","doi-asserted-by":"publisher","first-page":"3853","DOI":"10.1007\/s10067-020-05210-4","volume":"39","author":"S Ganh\u00e3o","year":"2020","unstructured":"Ganh\u00e3o S, Loureiro GB, Oliveira DR, dos-Reis-Maia R, Aguiar F, Quental R, Moura C, Barreira JL, Rodrigues M, Brito I (2020) Two cases of ADA2 deficiency presenting as childhood polyarteritis nodosa: novel ADA2 variant, atypical CNS manifestations, and literature review. Clin Rheumatol 39:3853\u20133860. https:\/\/doi.org\/10.1007\/s10067-020-05210-4","journal-title":"Clin Rheumatol"},{"key":"5711_CR30","doi-asserted-by":"publisher","first-page":"117","DOI":"10.3899\/jrheum.181384","volume":"47","author":"S \u00d6zen","year":"2020","unstructured":"\u00d6zen S, Batu ED, Ta\u015fkiran EZ, \u00d6zkara HA, \u00dcnal \u015e, G\u00fcleray N, Erden A, Karada\u01e7 \u00d6, G\u00fcmr\u00fck F, \u00c7etin M, S\u00f6nmez HE, Bilginer Y, Ayvaz D\u00c7, Tezcan I (2020) A monogenic disease with a variety of phenotypes: deficiency of adenosine deaminase 2. J Rheumatol 47:117\u2013125. https:\/\/doi.org\/10.3899\/jrheum.181384","journal-title":"J Rheumatol"},{"key":"5711_CR31","doi-asserted-by":"publisher","first-page":"2314","DOI":"10.1002\/art.39699","volume":"68","author":"S Nanthapisal","year":"2016","unstructured":"Nanthapisal S, Murphy C, Omoyinmi E, Hong Y, Standing A, Berg S, Ekelund M, Jolles S, Harper L, Youngstein T, Gilmour K, Klein NJ, Eleftheriou D, Brogan PA (2016) Deficiency of adenosine deaminase type 2: a description of phenotype and genotype in fifteen cases. Arthritis Rheumatol 68:2314\u20132322. https:\/\/doi.org\/10.1002\/art.39699","journal-title":"Arthritis Rheumatol"},{"key":"5711_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2019.01525","volume":"10","author":"AEA Surace","year":"2019","unstructured":"Surace AEA, Hedrich CM (2019) The role of epigenetics in autoimmune\/inflammatory disease. Front Immunol 10:1\u201316. https:\/\/doi.org\/10.3389\/fimmu.2019.01525","journal-title":"Front Immunol"},{"key":"5711_CR33","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1136\/annrheumdis-2016-210802","volume":"76","author":"R Caorsi","year":"2017","unstructured":"Caorsi R, Penco F, Grossi A, Insalaco A, Omenetti A, Alessio M, Conti G, Marchetti F, Picco P, Tommasini A, Martino S, Malattia C, Gallizi R, Podda RA, Salis A, Falcini F, Schena F, Garbarino F, Morreale A, Pardeo M, Ventrici C, Passarelli C, Zhou Q, Severino M, Gandolfo C, Damonte G, Martini A, Ravelli A, Aksentijevich I, Ceccherini I, Gattorno M (2017) ADA2 deficiency (DADA2) as an unrecognised cause of early onset polyarteritis nodosa and stroke: a multicentre national study. Ann Rheum Dis 76:1648\u20131656. https:\/\/doi.org\/10.1136\/annrheumdis-2016-210802","journal-title":"Ann Rheum Dis"},{"key":"5711_CR34","doi-asserted-by":"publisher","first-page":"e20172266","DOI":"10.1542\/peds.2017-2266","volume":"142","author":"E Van Nieuwenhove","year":"2018","unstructured":"Van Nieuwenhove E, Humblet-Baron S, Van Eyck L, De Somer L, Dooley J, Tousseyn T, Hershfield M, Liston A, Wouters C (2018) ADA2 deficiency mimicking idiopathic multicentric castleman disease. Pediatrics 142:e20172266. https:\/\/doi.org\/10.1542\/peds.2017-2266","journal-title":"Pediatrics"},{"key":"5711_CR35","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1038\/s41431-018-0130-6","volume":"26","author":"M Rama","year":"2018","unstructured":"Rama M, Duflos C, Melki I, Bessis D, Bonhomme A, Martin H, Doummar D, Valence S, Rodriguez D, Carme E, Genevieve D, Heimdal K, Insalaco A, Franck N, Queyrel-Moranne V, Tieulie N, London J, Uettwiller F, Georgin-Lavialle S, Belot A, Kon\u00e9-Paut I, Hentgen V, Boursier G, Touitou I, Sarrabay G (2018) A decision tree for the genetic diagnosis of deficiency of adenosine deaminase 2 (DADA2): a French reference centres experience. Eur J Hum Genet 26:960\u2013971. https:\/\/doi.org\/10.1038\/s41431-018-0130-6","journal-title":"Eur J Hum Genet"},{"key":"5711_CR36","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.neurad.2018.05.002","volume":"46","author":"E Bulut","year":"2019","unstructured":"Bulut E, Erden A, Karadag O, Oguz KK, Ozen S (2019) Deficiency of adenosine deaminase 2; special focus on central nervous system imaging. J Neuroradiol 46:193\u2013198. https:\/\/doi.org\/10.1016\/j.neurad.2018.05.002","journal-title":"J Neuroradiol"},{"key":"5711_CR37","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1016\/j.jaci.2018.01.012","volume":"141","author":"L Trotta","year":"2018","unstructured":"Trotta L, Martelius T, Siitonen T, Hautala T, H\u00e4m\u00e4l\u00e4inen S, Juntti H, Taskinen M, Ilander M, Andersson EI, Zavialov A, Kaustio M, Keski-Filppula R, Hershfield M, Mustjoki S, Tapiainen T, Sepp\u00e4nen M, Saarela J (2018) ADA2 deficiency: clonal lymphoproliferation in a subset of patients. J Allergy Clin Immunol 141:1534\u20131537.e8. https:\/\/doi.org\/10.1016\/j.jaci.2018.01.012","journal-title":"J Allergy Clin Immunol"},{"key":"5711_CR38","doi-asserted-by":"publisher","first-page":"2682","DOI":"10.1182\/blood-2017-07-798660","volume":"130","author":"H Hashem","year":"2017","unstructured":"Hashem H, Kumar AR, M\u00fcller I, Babor F, Bredius R, Dalal J, Hsu AP, Holland SM, Hickstein DD, Jolles S, Krance R, Sasa G, Taskinen M, Koskenvuo M, Saarela J, Van Montfrans J, Wilson K, Bosch B, Moens L, Hershfield M, Meyts I (2017) Hematopoietic stem cell transplantation rescues the hematological, immunological, and vascular phenotype in DADA2. Blood 130:2682\u20132688. https:\/\/doi.org\/10.1182\/blood-2017-07-798660","journal-title":"Blood"},{"key":"5711_CR39","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s00296-017-3740-3","volume":"38","author":"S Sahin","year":"2018","unstructured":"Sahin S, Adrovic A, Barut K, Ugurlu S, Turanli ET, Ozdogan H, Kasapcopur O (2018) Clinical, imaging and genotypical features of three deceased and five surviving cases with ADA2 deficiency. Rheumatol Int 38:129\u2013136. https:\/\/doi.org\/10.1007\/s00296-017-3740-3","journal-title":"Rheumatol Int"},{"key":"5711_CR40","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1016\/j.jaad.2020.03.110","volume":"83","author":"F Chasset","year":"2020","unstructured":"Chasset F, Fayand A, Moguelet P, Kouby F, Bonhomme A, Franck N, Goldman-l\u00e9vy G, Fraitag S, Barbaud A, Queyrel V, Touitou I, Boursier G, Sarrabay G, Ducharme-Benard S, Dupin N, Franc\u00e8s C, Bessis D, Georgin-Lavialle S (2020) Clinical and pathological dermatological features of deficiency of adenosine deaminase 2: multicenter retrospective observational study. J Am Acad Dermatol 83:1794\u20131798. https:\/\/doi.org\/10.1016\/j.jaad.2020.03.110","journal-title":"J Am Acad Dermatol"},{"key":"5711_CR41","first-page":"142","volume":"37","author":"GTJ van Well","year":"2019","unstructured":"van Well GTJ, Kant B, van Nistelrooij A, Sirma Ekmekci S, Henriet SV, Hoppenreijs E, van Deuren M, van Montfrans J, Nierkens S, G\u00fcl A, van Gijn ME (2019) Phenotypic variability including Beh\u00e7et\u2019s disease-like manifestations in DADA2 patients due to a homozygous c.973-2A > G splice site mutation. Clin Exp Rheumatol 37:142\u2013146","journal-title":"Clin Exp Rheumatol"},{"key":"5711_CR42","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1159\/000495794","volume":"46","author":"GC Santo","year":"2019","unstructured":"Santo GC, Baldeiras I, Guerreiro R, Ribeiro JA, Cunha R, Youngstein T, Nanthapisal S, Leit\u00e3o J, Fernandes C, Caramelo F, Almeida MDR, Br\u00e1s J, Santana I (2019) Adenosine deaminase two and immunoglobulin M accurately differentiate adult Sneddon\u2019s syndrome of unknown cause. Cerebrovasc Dis 46:257\u2013264. https:\/\/doi.org\/10.1159\/000495794","journal-title":"Cerebrovasc Dis"},{"key":"5711_CR43","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s00296-019-04444-z","volume":"41","author":"B Sozeri","year":"2019","unstructured":"Sozeri B, Ercan G, Dogan OA, Y\u0131ld\u0131z J, Demir F, Do\u011fanay L (2019) The same mutation in a family with adenosine deaminase 2 deficiency. Rheumatol Int 41:227\u2013233. https:\/\/doi.org\/10.1007\/s00296-019-04444-z","journal-title":"Rheumatol Int"},{"key":"5711_CR44","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.jpeds.2016.06.058","volume":"177","author":"T Ben-Ami","year":"2016","unstructured":"Ben-Ami T, Revel-Vilk S, Brooks R, Shaag A, Hershfield MS, Kelly SJ, Ganson NJ, Kfir-Erenfeld S, Weintraub M, Elpeleg O, Berkun Y, Stepensky P (2016) Extending the clinical phenotype of adenosine deaminase 2 deficiency. J Pediatr 177:316\u2013320. https:\/\/doi.org\/10.1016\/j.jpeds.2016.06.058","journal-title":"J Pediatr"},{"key":"5711_CR45","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s10875-019-00734-0","volume":"40","author":"A Tanatar","year":"2020","unstructured":"Tanatar A, Karada\u011f \u015eG, S\u00f6zeri B, S\u00f6nmez HE, \u00c7akan M, Kendir Demirkol Y, Aktay Ayaz N (2020) ADA2 deficiency: case series of five patients with varying phenotypes. J Clin Immunol 40:253\u2013258. https:\/\/doi.org\/10.1007\/s10875-019-00734-0","journal-title":"J Clin Immunol"},{"key":"5711_CR46","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3899\/jrheum.150024","volume":"42","author":"ED Batu","year":"2015","unstructured":"Batu ED, Karadag O, Taskiran EZ, Kalyoncu U, Aksentijevich I, Alikasifoglu M, \u00d6zen S, Series AC, Patients D (2015) A case series of adenosine deaminase 2-deficient patients emphasizing treatment and genotype-phenotype correlations The Journal of Rheumatology is a monthly international serial edited by Earl D . Silverman featuring research a. J Rheumatol 42:8\u201311","journal-title":"J Rheumatol"},{"key":"5711_CR47","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.3899\/jrheum.180820","volume":"46","author":"J Liebowitz","year":"2019","unstructured":"Liebowitz J, Hellmann DB, Schnappauf O (2019) Thirty years of followup in 3 patients with familial polyarteritis nodosa due to adenosine deaminase 2 deficiency. J Rheumatol 46:1059\u20131060. https:\/\/doi.org\/10.3899\/jrheum.180820","journal-title":"J Rheumatol"},{"key":"5711_CR48","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.jaci.2014.10.010","volume":"135","author":"L Van Eyck","year":"2015","unstructured":"Van Eyck L, Hershfield MS, Pombal D, Kelly SJ, Ganson NJ, Moens L, Frans G, Schaballie H, De Hertogh G, Dooley J, Bossuyt X, Wouters C, Liston A, Meyts I (2015) Hematopoietic stem cell transplantation rescues the immunologic phenotype and prevents vasculopathy in patients with adenosine deaminase 2 deficiency. J Allergy Clin Immunol 135:283\u2013287.e5. https:\/\/doi.org\/10.1016\/j.jaci.2014.10.010","journal-title":"J Allergy Clin Immunol"},{"key":"5711_CR49","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1007\/s00415-016-8070-y","volume":"263","author":"F d O Poswar","year":"2016","unstructured":"Poswar F d O, da Fonseca RMT, de Albuquerque LCP, Zhou Q, Jardim LB, Monte TL, Aksentijevich I, Saute JAM (2016) Adenosine deaminase 2 deficiency presenting as spastic paraplegia and systemic vasculitis. J Neurol 263:818\u2013820. https:\/\/doi.org\/10.1007\/s00415-016-8070-y","journal-title":"J Neurol"},{"key":"5711_CR50","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1212\/WNL.0000000000001581","volume":"84","author":"WF Westendorp","year":"2015","unstructured":"Westendorp WF, Nederkoorn PJ, Aksentijevich I, Hak AE, Lichtenbelt KD, Braun KPJ (2015) Unexplained early-onset lacunar stroke and inflammatory skin lesions: consider ADA2 deficiency. Neurology 84:2092\u20132093. https:\/\/doi.org\/10.1212\/WNL.0000000000001581","journal-title":"Neurology"},{"key":"5711_CR51","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1007\/s10875-018-0480-4","volume":"38","author":"TF Michniacki","year":"2018","unstructured":"Michniacki TF, Hannibal M, Ross CW, Frame DG, DuVall AS, Khoriaty R, Vander Lugt MT, Walkovich KJ (2018) Hematologic manifestations of deficiency of adenosine deaminase 2 (DADA2) and response to tumor necrosis factor inhibition in DADA2-associated bone marrow failure. J Clin Immunol 38:166\u2013173. https:\/\/doi.org\/10.1007\/s10875-018-0480-4","journal-title":"J Clin Immunol"},{"key":"5711_CR52","doi-asserted-by":"publisher","unstructured":"Krutzke S, Horneff G (2019) Treatment of two male children suffering from deficiency of adenosine deaminase type 2 (DADA2) with TNF-inhibitor etanercept. J Clin Rheumatol. Publish Ahead of Print. https:\/\/doi.org\/10.1097\/RHU.0000000000001145","DOI":"10.1097\/RHU.0000000000001145"},{"key":"5711_CR53","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1016\/j.jaci.2015.07.053","volume":"137","author":"F Fellmann","year":"2016","unstructured":"Fellmann F, Angelini F, Wassenberg J, Perreau M, Arenas Ramirez N, Simon G, Boyman O, Demaria O, Christen-Zaech S, Hohl D, Belfiore M, Von Scheven-Gete A, Gilliet M, Bochud PY, Perrin Y, Beck Popovic M, Bart PA, Beckmann JS, Martinet D, Hofer M (2016) IL-17 receptor A and adenosine deaminase 2 deficiency in siblings with recurrent infections and chronic inflammation. J Allergy Clin Immunol 137:1189\u20131196.e2. https:\/\/doi.org\/10.1016\/j.jaci.2015.07.053","journal-title":"J Allergy Clin Immunol"},{"key":"5711_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2018.01361","volume":"9","author":"JM Springer","year":"2018","unstructured":"Springer JM, Gierer SA, Jiang H, Kleiner D, Deuitch N, Ombrello AK, Grayson PC, Aksentijevich I (2018) Deficiency of adenosine deaminase 2 in adult siblings: many years of a misdiagnosed disease with severe consequences. Front Immunol 9:1\u20135. https:\/\/doi.org\/10.3389\/fimmu.2018.01361","journal-title":"Front Immunol"},{"key":"5711_CR55","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1001\/jamadermatol.2015.1635","volume":"151","author":"TMG Santiago","year":"2015","unstructured":"Santiago TMG, Zavialov A, Saarela J, Seppanen M, Reed AM, Abraham RS, Gibson LE (2015) Dermatologic features of ADA2 deficiency in cutaneous polyarteritis nodosa. JAMA Dermatol 151:1230\u20131234. https:\/\/doi.org\/10.1001\/jamadermatol.2015.1635","journal-title":"JAMA Dermatol"},{"key":"5711_CR56","doi-asserted-by":"publisher","first-page":"e60","DOI":"10.1111\/bjh.15896","volume":"186","author":"RR Ghurye","year":"2019","unstructured":"Ghurye RR, Sundaram K, Smith F, Clark B, Simpson MA, Fairbanks L, Adhya Z, Mufti GJ, Marsh JCW, Ibrahim MAA (2019) Novel ADA2 mutation presenting with neutropenia, lymphopenia and bone marrow failure in patients with deficiency in adenosine deaminase 2 (DADA2). Br J Haematol 186:e60\u2013e64. https:\/\/doi.org\/10.1111\/bjh.15896","journal-title":"Br J Haematol"},{"key":"5711_CR57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12969-019-0334-5","volume":"17","author":"K Clarke","year":"2019","unstructured":"Clarke K, Campbell C, Omoyinmi E, Hong Y, Al Obaidi M, Sebire N, Brogan PA (2019) Testicular ischemia in deficiency of adenosine deaminase 2 (DADA2). Pediatr Rheumatol 17:1\u20137. https:\/\/doi.org\/10.1186\/s12969-019-0334-5","journal-title":"Pediatr Rheumatol"},{"key":"5711_CR58","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1101\/mcs.a003384","volume":"4","author":"D Claassen","year":"2018","unstructured":"Claassen D, Boals M, Bowling KM, Cooper GM, Cox J, Hershfield M, Lewis S, Wlodarski M, Weiss MJ, Estepp JH (2018) Complexities of genetic diagnosis illustrated by an atypical case of congenital hypoplastic anemia. Cold Spring Harb Mol Case Stud 4:2\u20137. https:\/\/doi.org\/10.1101\/mcs.a003384","journal-title":"Cold Spring Harb Mol Case Stud"},{"key":"5711_CR59","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.3324\/haematol.2019.216069","volume":"105","author":"M Neishabury","year":"2020","unstructured":"Neishabury M, Mehri M, Fattahi Z, Najmabadi H, Azarkeivan A (2020) Novel variants in Iranian individuals suspected to have inherited red blood cell disorders, including bone marrow failure syndromes. Haematologica 105:E1\u2013E4","journal-title":"Haematologica"},{"key":"5711_CR60","doi-asserted-by":"publisher","unstructured":"Keino D, Kondoh K, Kim Y, Sudo A, Ohyama R, Morimoto M, Nihira H, Izawa K, Iwaki-Egawa S, Mori T, Kinoshita A (2020) Successful treatment with cyclosporine and anti-tumour necrosis factor agent for deficiency of adenosine deaminase-2. Scand J Rheumatol. 28:1\u20133.\u00a0https:\/\/doi.org\/10.1080\/03009742.2020.1772868","DOI":"10.1080\/03009742.2020.1772868"},{"key":"5711_CR61","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1111\/cge.13518","volume":"95","author":"A Grossi","year":"2019","unstructured":"Grossi A, Cusano R, Rusmini M, Penco F, Schena F, Podda RA, Caorsi R, Gattorno M, Uva P, Ceccherini I (2019) ADA2 deficiency due to a novel structural variation in 22q11.1. Clin Genet 95:732\u2013733. https:\/\/doi.org\/10.1111\/cge.13518","journal-title":"Clin Genet"},{"key":"5711_CR62","first-page":"146","volume":"36","author":"I Maccora","year":"2018","unstructured":"Maccora I, Frongia I, Azzari C, Ricci S, Cimaz R, Simonini G (2018) A misleading case of deficiency of adenosine deaminase 2 (DADA2): the magnifying glass of the scientific knowledge drives the tailored medicine in real life. Clin Exp Rheumatol 36:146","journal-title":"Clin Exp Rheumatol"},{"key":"5711_CR63","doi-asserted-by":"publisher","unstructured":"Barzaghi F, Minniti F, Mauro M, De Bortoli M, Balter R, Bonetti E, Zaccaron A, Vitale V, Omrani M, Zoccolillo M, Brigida I, Cicalese MP, Degano M, Hershfield MS, Aiuti A, Bondarenko AV, Chinello M, Cesaro S (2019) ALPS-like phenotype caused by ADA2 deficiency rescued by allogeneic hematopoietic stem cell transplantation. Front Immunol 10. https:\/\/doi.org\/10.3389\/fimmu.2018.02767","DOI":"10.3389\/fimmu.2018.02767"},{"key":"5711_CR64","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1080\/08880018.2019.1621973","volume":"36","author":"RMK Ekinci","year":"2019","unstructured":"Ekinci RMK, Balc\u0131 S, Bisgin A, Sasmaz I, Leblebisatan G, Incecik F, Yilmaz M (2019) A homozygote novel L451W mutation in CECR1 gene causes deficiency of adenosine deaminase 2 in a pediatric patient representing with chronic lymphoproliferation and cytopenia. Pediatr Hematol Oncol 36:376\u2013381. https:\/\/doi.org\/10.1080\/08880018.2019.1621973","journal-title":"Pediatr Hematol Oncol"},{"key":"5711_CR65","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s10875-018-0487-x","volume":"38","author":"FE Cipe","year":"2018","unstructured":"Cipe FE, Aydogmus C, Serwas NK, Keskindemirci G, Boztu\u011f K (2018) Novel mutation in CECR1 leads to deficiency of ADA2 with associated neutropenia. J Clin Immunol 38:273\u2013277. https:\/\/doi.org\/10.1007\/s10875-018-0487-x","journal-title":"J Clin Immunol"},{"key":"5711_CR66","doi-asserted-by":"publisher","unstructured":"Dimachkie MD, Fraga GR, Moura NS, Springer JM (2020) A rare case of adenosine deaminase 2 deficiency presenting with temporal arteritis. J Clin Rheumatol: Publish Ahead of Print. https:\/\/doi.org\/10.1097\/rhu.0000000000001384","DOI":"10.1097\/rhu.0000000000001384"},{"key":"5711_CR67","doi-asserted-by":"publisher","first-page":"413","DOI":"10.24953\/turkjped.2019.03.014","volume":"61","author":"M \u00c7akan","year":"2019","unstructured":"\u00c7akan M, Aktay-Ayaz N, Karada\u011f \u015eG, Tahir-Turanl\u0131 E, Stafstrom K, Bainter W, Geha RS, Chou J (2019) Atypical phenotype of an old disease or typical phenotype of a new disease: deficiency of adenosine deaminase 2. Turk J Pediatr 61:413\u2013417. https:\/\/doi.org\/10.24953\/turkjped.2019.03.014","journal-title":"Turk J Pediatr"},{"key":"5711_CR68","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1002\/pbc.26912","volume":"65","author":"A Alsultan","year":"2018","unstructured":"Alsultan A, Basher E, Alqanatish J, Mohammed R, Alfadhel M (2018) Deficiency of ADA2 mimicking autoimmune lymphoproliferative syndrome in the absence of livedo reticularis and vasculitis. Pediatr Blood Cancer 65:10\u201313. https:\/\/doi.org\/10.1002\/pbc.26912","journal-title":"Pediatr Blood Cancer"},{"key":"5711_CR69","doi-asserted-by":"publisher","first-page":"e293","DOI":"10.1097\/MPH.0000000000000805","volume":"39","author":"H Hashem","year":"2017","unstructured":"Hashem H, Egler R, Dalal J (2017) Refractory pure red cell aplasia manifesting as deficiency of adenosine deaminase 2. J Pediatr Hematol Oncol 39:e293\u2013e296. https:\/\/doi.org\/10.1097\/MPH.0000000000000805","journal-title":"J Pediatr Hematol Oncol"},{"key":"5711_CR70","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1093\/rheumatology\/kew050","volume":"55","author":"N Keer","year":"2016","unstructured":"Keer N, Hershfield M, Caskey T, Unizony S (2016) Novel compound heterozygous variants in CECR1 gene associated with childhood onset polyarteritis nodosa and deficiency of ADA2. Rheumatology (Oxford) 55:1145\u20131147. https:\/\/doi.org\/10.1093\/rheumatology\/kew050","journal-title":"Rheumatology (Oxford)"},{"key":"5711_CR71","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1684\/ejd.2018.3427","volume":"28","author":"H Martin","year":"2018","unstructured":"Martin H, Bursztejn AC, Cuny JF, Sarrabay G, Schmutz JL, Touitou I, Wahl D, Bonhomme A (2018) Chronic leg ulcer revealing adenosine deaminase 2 deficiency: an atypical presentation. Eur J Dermatol 28:847\u2013848","journal-title":"Eur J Dermatol"},{"key":"5711_CR72","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1055\/s-0036-1597611","volume":"48","author":"M Elbracht","year":"2017","unstructured":"Elbracht M, Mull M, Wagner N, Kuhl C, Abicht A, Kurth I, Tenbrock K, H\u00e4usler M (2017) Stroke as initial manifestation of adenosine deaminase 2 deficiency. Neuropediatrics 48:111\u2013114. https:\/\/doi.org\/10.1055\/s-0036-1597611","journal-title":"Neuropediatrics"},{"key":"5711_CR73","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1080\/03009742.2017.1324912","volume":"47","author":"H Nihira","year":"2018","unstructured":"Nihira H, Nakagawa K, Izawa K, Kawai T, Yasumi T, Nishikomori R, Nambu M, Miyagawa-Hayashino A, Nomura T, Kabashima K, Ito M, Iwaki-Egawa S, Sasahara Y, Nakayama M, Heike T (2018) Fever of unknown origin with rashes in early infancy is indicative of adenosine deaminase type 2 deficiency. Scand J Rheumatol 47:170\u2013172. https:\/\/doi.org\/10.1080\/03009742.2017.1324912","journal-title":"Scand J Rheumatol"},{"key":"5711_CR74","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.jaci.2016.03.016","volume":"138","author":"AP Hsu","year":"2016","unstructured":"Hsu AP, West RR, Calvo KR, Cuellar-Rodriguez J, Parta M, Kelly SJ, Ganson NJ, Hershfield MS, Holland SM, Hickstein DD (2016) Adenosine deaminase type 2 deficiency masquerading as GATA2 deficiency: Successful hematopoietic stem cell transplantation. J Allergy Clin Immunol 138:628\u2013630.e2. https:\/\/doi.org\/10.1016\/j.jaci.2016.03.016","journal-title":"J Allergy Clin Immunol"},{"key":"5711_CR75","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s00251-018-01101-w","volume":"71","author":"L Liu","year":"2019","unstructured":"Liu L, Wang W, Wang Y, Hou J, Ying W, Hui X, Zhou Q, Liu D, Yao H, Sun J, Wang X (2019) A Chinese DADA2 patient: report of two novel mutations and successful HSCT. Immunogenetics 71:299\u2013305. https:\/\/doi.org\/10.1007\/s00251-018-01101-w","journal-title":"Immunogenetics"},{"key":"5711_CR76","doi-asserted-by":"publisher","first-page":"e20180948","DOI":"10.1542\/peds.2018-0948","volume":"142","author":"RMK Ekinci","year":"2018","unstructured":"Ekinci RMK, Balci S, Bisgin A, Hershfield M, Atmis B, Dogruel D, Yilmaz M (2018) Renal amyloidosis in deficiency of adenosine deaminase 2: Successful experience with canakinumab. Pediatrics 142:e20180948. https:\/\/doi.org\/10.1542\/peds.2018-0948","journal-title":"Pediatrics"},{"key":"5711_CR77","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1080\/20469047.2018.1559495","volume":"40","author":"S Sahin","year":"2020","unstructured":"Sahin S, Adrovic A, Barut K, Baran S, Tahir Turanli E, Canpolat N, Kizilkilic O, Ozkaya O, Kasapcopur O (2020) A 9.5-year-old boy with recurrent neurological manifestations and severe hypertension, treated initially for polyarteritis nodosa, was subsequently diagnosed with adenosine deaminase type 2 deficiency (DADA2) which responded to anti-TNF-\u03b1. Paediatr Int Child Health 40:65\u201368. https:\/\/doi.org\/10.1080\/20469047.2018.1559495","journal-title":"Paediatr Int Child Health"},{"key":"5711_CR78","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1097\/MPH.0000000000001132","volume":"41","author":"M Sundin","year":"2019","unstructured":"Sundin M, Marits P, Nierkens S, Kolios AGA, Nilsson J (2019) Immune thrombocytopenia as key feature of a novel ADA2 deficiency variant: implication on differential diagnostics of ITP in children. J Pediatr Hematol Oncol 41:155\u2013157. https:\/\/doi.org\/10.1097\/MPH.0000000000001132","journal-title":"J Pediatr Hematol Oncol"},{"key":"5711_CR79","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1056\/nejmc1405506","volume":"371","author":"L Van Eyck","year":"2014","unstructured":"Van Eyck L, Liston A, Wouters C (2014) Mutant ADA2 in vasculopathies. N Engl J Med 371:478\u2013481. https:\/\/doi.org\/10.1056\/nejmc1405506","journal-title":"N Engl J Med"},{"key":"5711_CR80","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1007\/s10875-018-0565-0","volume":"38","author":"K Arts","year":"2018","unstructured":"Arts K, Bergerson JRE, Ombrello AK, Similuk M, Oler AJ, Agharahimi A, Mace EM, Hershfield M, Wouters C, De Somer L, Morren MA, de Diego RP, Moens L, Freeman AF, Meyts I (2018) Warts and DADA2: a mere coincidence? J Clin Immunol 38:836\u2013843. https:\/\/doi.org\/10.1007\/s10875-018-0565-0","journal-title":"J Clin Immunol"},{"key":"5711_CR81","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s10875-019-00700-w","volume":"40","author":"L G\u00f6schl","year":"2020","unstructured":"G\u00f6schl L, Winkler S, Dmytrus J, Heredia RJ, Lagler H, Ramharter M, Scheinecker C, Bonelli M, Schmetterer K, Pickl WF, Grabmeier-Pfistershammer K, Hershfield MS, Boztug K, F\u00f6rster-Waldl E, Gualdoni GA (2020) Unreported missense mutation in the dimerization domain of ADA2 leads to ADA2 deficiency associated with severe oral ulcers and neutropenia in a female Somalian patient\u2014addendum to the genotype-phenotype puzzle. J Clin Immunol 40:223\u2013226. https:\/\/doi.org\/10.1007\/s10875-019-00700-w","journal-title":"J Clin Immunol"},{"key":"5711_CR82","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1093\/rheumatology\/kez446","volume":"59","author":"TJ Tull","year":"2020","unstructured":"Tull TJ, Martin B, Spencer J, Sangle S, Chua S, McGrath JA, D\u2019Cruz DP, McGibbon DH (2020) Sneddon syndrome associated with two novel ADA2 gene mutations. Rheumatology (Oxford) 59:1448\u20131450. https:\/\/doi.org\/10.1093\/rheumatology\/kez446","journal-title":"Rheumatology (Oxford)"},{"key":"5711_CR83","doi-asserted-by":"publisher","first-page":"108525","DOI":"10.1016\/j.clim.2020.108525","volume":"218","author":"F Saettini","year":"2020","unstructured":"Saettini F, Fazio G, Corti P, Quadri M, Bugarin C, Gaipa G, Penco F, Moratto D, Chiarini M, Baronio M, Gazzurelli L, Imberti L, Paghera S, Giliani S, Cazzaniga G, Plebani A, Badolato R, Lougaris V, Gattorno M, Biondi A (2020) Two siblings presenting with novel ADA2 variants, lymphoproliferation, persistence of large granular lymphocytes, and T cell perturbations. Clin Immunol 218:108525. https:\/\/doi.org\/10.1016\/j.clim.2020.108525","journal-title":"Clin Immunol"},{"key":"5711_CR84","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s10875-019-0590-7","volume":"39","author":"F Alabbas","year":"2019","unstructured":"Alabbas F, Elyamany G, Alsharif O, Hershfield M, Meyts I (2019) Childhood Hodgkin lymphoma: think DADA2. J Clin Immunol 39:26\u201329. https:\/\/doi.org\/10.1007\/s10875-019-0590-7","journal-title":"J Clin Immunol"},{"key":"5711_CR85","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1007\/s10875-020-00812-8","volume":"40","author":"T Le Voyer","year":"2020","unstructured":"Le Voyer T, Boutboul D, Ledoux-Pilon A, de Fontbrune FS, Boursier G, Latour S, Le Guenno G (2020) Late-onset EBV susceptibility and refractory pure red cell aplasia revealing DADA2. J Clin Immunol 40:948\u2013953. https:\/\/doi.org\/10.1007\/s10875-020-00812-8","journal-title":"J Clin Immunol"},{"key":"5711_CR86","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.clim.2020.108443","volume":"215","author":"E Staples","year":"2020","unstructured":"Staples E, Simeoni I, Stephens JC, Allen HL, Wright P, Davies EG, Javid B, Gkrania-Klotsas E, Gattens M, Firth H, Shamardina O, Deevi SVV, Prapa M, Uttenthal B, Kumararatne D, Thaventhiran JED (2020) ADA2 deficiency complicated by EBV-driven lymphoproliferative disease. Clin Immunol 215:22\u201325. https:\/\/doi.org\/10.1016\/j.clim.2020.108443","journal-title":"Clin Immunol"},{"key":"5711_CR87","doi-asserted-by":"publisher","first-page":"236","DOI":"10.4103\/injr.injr_36_19","volume":"14","author":"Z Al Mosawi","year":"2019","unstructured":"Al Mosawi Z, Abduljawad H, Busehail M, Al Moosawi B (2019) Adenosine deaminase 2 deficiency with a novel variant of CECR1 gene mutation: responding to tumor necrosis factor antagonist therapy. Indian J Rheumatol 14:236\u2013240. https:\/\/doi.org\/10.4103\/injr.injr_36_19","journal-title":"Indian J Rheumatol"},{"key":"5711_CR88","doi-asserted-by":"publisher","first-page":"2474","DOI":"10.1002\/ajmg.a.61363","volume":"179","author":"O Akgun-Dogan","year":"2019","unstructured":"Akgun-Dogan O, Simsek-Kiper PO, Taskiran E, Lissewski C, Brinkmann J, Schanze D, G\u00f6\u00e7men R, Cagdas D, Bilginer Y, Utine GE, Zenker M, Ozen S, Tezcan \u0130, Alikasifoglu M, Boduro\u011flu K (2019) ADA2 deficiency in a patient with Noonan syndrome-like disorder with loose anagen hair: The co-occurrence of two rare syndromes. Am J Med Genet A 179:2474\u20132480. https:\/\/doi.org\/10.1002\/ajmg.a.61363","journal-title":"Am J Med Genet A"},{"key":"5711_CR89","doi-asserted-by":"publisher","first-page":"E66","DOI":"10.1097\/RHU.0000000000000839","volume":"26","author":"V Teixeira","year":"2020","unstructured":"Teixeira V, Oliveira-Ramos F, Teixeira V, Oliveira-Ramos F, Costa M (2020) Severe and refractory polyarteritis nodosa associated with CECR1 mutation and dramatic response to infliximab in adulthood. J Clin Rheumatol 26:E66\u2013E69","journal-title":"J Clin Rheumatol"},{"key":"5711_CR90","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1093\/rheumatology\/key258","volume":"58","author":"A Sharma","year":"2019","unstructured":"Sharma A, Naidu GSRSNK, Chattopadhyay A, Acharya N, Jha S, Jain S (2019) Novel CECR1 gene mutations causing deficiency of adenosine deaminase 2, mimicking antiphospholipid syndrome. Rheumatology (Oxford) 58:181\u2013182. https:\/\/doi.org\/10.1093\/rheumatology\/key258","journal-title":"Rheumatology (Oxford)"},{"key":"5711_CR91","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1002\/art.41549","volume":"73","author":"O Schnappauf","year":"2020","unstructured":"Schnappauf O, Sampaio Moura N, Aksentijevich I, Stoffels M, Ombrello AK, Hoffmann P, Barron K, Remmers EF, Hershfield M, Kelly SJ, Cuthbertson D, Carette S, Chung SA, Forbess L, Khalidi NA, Koening CL, Langford CA, McAlear CA, Monach PA, Moreland L, Pagnoux C, Seo P, Springer JM, Sreih AG, Warrington KJ, Ytterberg SR, Kastner DL, Grayson PC, Merkel PA (2020) Sequence-based screening of patients with idiopathic polyarteritis nodosa, granulomatosis with polyangiitis, and microscopic polyangiitis for deleterious genetic variants in ADA2. Arthritis Rheumatol. 73:512\u2013519. https:\/\/doi.org\/10.1002\/art.41549","journal-title":"Arthritis Rheumatol."},{"key":"5711_CR92","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s10875-016-0245-x","volume":"36","author":"J Schepp","year":"2016","unstructured":"Schepp J, Bulashevska A, Mannhardt-Laakmann W, Cao H, Yang F, Seidl M, Kelly S, Hershfield M, Grimbacher B (2016) Deficiency of adenosine deaminase 2 causes antibody deficiency. J Clin Immunol 36:179\u2013186. https:\/\/doi.org\/10.1007\/s10875-016-0245-x","journal-title":"J Clin Immunol"},{"key":"5711_CR93","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1056\/NEJMc1801927","volume":"380","author":"AK Ombrello","year":"2019","unstructured":"Ombrello AK, Bethesda QJ, Bethesda HPM, Bethesda KP, Bethesda SD, Jones A, Romeo T, Barham B, Pinto-Patarroyo G, Toro C, Soldatos A, Zhou Q, Deuitch N, Aksentijevich I, Sheldon SL, Kelly S, Man A, Barron K, Hershfield M, Flegel WA, Kastner DL (2019) Treatment strategies for deficiency of adenosine deaminase 2. N Engl J Med 380:1582\u20131584. https:\/\/doi.org\/10.1056\/NEJMc1801927","journal-title":"N Engl J Med"},{"key":"5711_CR94","doi-asserted-by":"publisher","first-page":"O40","DOI":"10.1186\/1546-0096-13-s1-o40","volume":"13","author":"A Ombrello","year":"2015","unstructured":"Ombrello A, Stone D, Hoffmann P, Jones A, Barham B, Barron K, Flegel W, Sheldon S, Zhou Q, Hershfield M, Aksentijevich I, Kumar P, Kastner D (2015) The deficiency of adenosine deaminase type 2-results of therapeutic intervention. Pediatr Rheumatol 13:O40. https:\/\/doi.org\/10.1186\/1546-0096-13-s1-o40","journal-title":"Pediatr Rheumatol"},{"key":"5711_CR95","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1038\/bmt.2017.173","volume":"52","author":"H Hashem","year":"2017","unstructured":"Hashem H, Vatsayan A, Gupta A, Nagle K, Hershfield M, Dalal J (2017) Successful reduced intensity hematopoietic cell transplant in a patient with deficiency of adenosine deaminase 2. Bone Marrow Transplant 52:1575\u20131576. https:\/\/doi.org\/10.1038\/bmt.2017.173","journal-title":"Bone Marrow Transplant"},{"key":"5711_CR96","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1007\/s10875-017-0449-8","volume":"37","author":"G Bucciol","year":"2017","unstructured":"Bucciol G, Delafontaine S, Segers H, Bossuyt X, Hershfield MS, Moens L, Meyts I (2017) Hematopoietic stem cell transplantation in ADA2 deficiency: early restoration of ADA2 enzyme activity and disease relapse upon drop of donor chimerism. J Clin Immunol 37:746\u2013750. https:\/\/doi.org\/10.1007\/s10875-017-0449-8","journal-title":"J Clin Immunol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-021-05711-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-021-05711-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-021-05711-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,24]],"date-time":"2023-10-24T14:56:22Z","timestamp":1698159382000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-021-05711-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,31]]},"references-count":96,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["5711"],"URL":"https:\/\/doi.org\/10.1007\/s10067-021-05711-w","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,31]]},"assertion":[{"value":"23 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from the patients for publication of this case report and related clinical images.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}